Ewopharma is the successor company to M.R. Leclerc & Co., founded in 1959. From the start, our focus has been on building bridges to the pharmaceutical markets of Central Eastern Europe. Much has changed in the region since 1959 – both economically and politically – and over this period we have gained an in-depth understanding of the markets and an esteemed standing there.
While we started out purely as a marketing partner for pharmaceutical companies, we have since acquired and launched proprietary products. Our brand Revalid® – a product line for holistic hair care and hair loss treatment–was developed in 1992 in Switzerland. In 2011, we acquired Irish healthcare company Newport Pharmaceuticals Ltd. giving us full ownership of the antiviral drug Isoprinosine® in 2011.Overseen by our head office in Schaffhausen, Switzerland, we now channel our industry knowledge and experience into the successful placement of both Ewopharma and partner brands in our target markets. In 2004, we joined the RX-Alliance, a professional cooperation network of successful pharmaceutical companies active in selected European markets.

Pharmaceutical

Ewopharma

Alain Staub

Reto Schaberl

Antonio Mantarro

Andreas Kübler

Marketing and Sales

Business Management

Medical and Regulatory Affairs

Product Management Team

Operations and Compliance Team

Sales and Business Development

��

Ewopharma

Org chart

Teams

Marketing and Sales

Business Management

Medical and Regulatory Affairs

Product Management Team

Operations and Compliance Team

Sales and Business Development

Similar companies

��������

Ewopharma

Org chart

Teams

Marketing and Sales

Business Management

Medical and Regulatory Affairs

Product Management Team

Operations and Compliance Team

Sales and Business Development

Similar companies

��